BAX vs. DOCS: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at BAX and DOCS, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Profile
| Symbol | BAX | DOCS |
|---|---|---|
| Company Name | Baxter International Inc. | Doximity, Inc. |
| Country | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry | Health Care Equipment & Supplies | Health Care Technology |
| Market Capitalization | 9.36 billion USD | 9.17 billion USD |
| Exchange | NYSE | NYSE |
| Listing Date | October 27, 1981 | June 24, 2021 |
| Security Type | Common Stock | Common Stock |
Historical Performance
This chart compares the performance of BAX and DOCS by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.
Historical Performance at a Glance
| Symbol | BAX | DOCS |
|---|---|---|
| 5-Day Price Return | 4.06% | -5.56% |
| 13-Week Price Return | -23.61% | -23.81% |
| 26-Week Price Return | -40.71% | -17.89% |
| 52-Week Price Return | -43.40% | -6.13% |
| Month-to-Date Return | 0.00% | -24.82% |
| Year-to-Date Return | -36.66% | -7.06% |
| 10-Day Avg. Volume | 10.18M | 2.51M |
| 3-Month Avg. Volume | 7.70M | 1.57M |
| 3-Month Volatility | 39.93% | 42.88% |
| Beta | 0.58 | 1.42 |
Profitability
Return on Equity (TTM)
BAX
-4.77%
Health Care Equipment & Supplies Industry
- Max
- 29.82%
- Q3
- 15.54%
- Median
- 9.69%
- Q1
- 5.19%
- Min
- -7.98%
BAX has a negative Return on Equity of -4.77%. This indicates the company is generating a loss for its shareholders, which can be a result of unprofitability or negative shareholder equity and is often a sign of financial distress.
DOCS
23.90%
Health Care Technology Industry
- Max
- 48.09%
- Q3
- 42.04%
- Median
- 18.65%
- Q1
- 11.64%
- Min
- 11.05%
DOCS’s Return on Equity of 23.90% is on par with the norm for the Health Care Technology industry, indicating its profitability relative to shareholder equity is typical for the sector.
Net Profit Margin (TTM)
BAX
-3.09%
Health Care Equipment & Supplies Industry
- Max
- 24.65%
- Q3
- 14.10%
- Median
- 10.09%
- Q1
- 5.84%
- Min
- -6.13%
BAX has a negative Net Profit Margin of -3.09%, indicating the company is operating at a net loss as its expenses exceeded its revenues.
DOCS
40.72%
Health Care Technology Industry
- Max
- 52.24%
- Q3
- 49.36%
- Median
- 34.00%
- Q1
- 16.86%
- Min
- 13.38%
DOCS’s Net Profit Margin of 40.72% is aligned with the median group of its peers in the Health Care Technology industry. This indicates its ability to convert revenue into profit is typical for the sector.
Operating Profit Margin (TTM)
BAX
-0.13%
Health Care Equipment & Supplies Industry
- Max
- 31.34%
- Q3
- 18.36%
- Median
- 15.07%
- Q1
- 9.62%
- Min
- -0.13%
BAX has a negative Operating Profit Margin of -0.13%. This signifies the company is unprofitable at the operational level, as its core business expenses exceed its revenue.
DOCS
39.72%
Health Care Technology Industry
- Max
- 74.05%
- Q3
- 65.47%
- Median
- 33.33%
- Q1
- 22.83%
- Min
- 21.46%
DOCS’s Operating Profit Margin of 39.72% is around the midpoint for the Health Care Technology industry, indicating that its efficiency in managing core business operations is typical for the sector.
Profitability at a Glance
| Symbol | BAX | DOCS |
|---|---|---|
| Return on Equity (TTM) | -4.77% | 23.90% |
| Return on Assets (TTM) | -1.53% | 20.66% |
| Net Profit Margin (TTM) | -3.09% | 40.72% |
| Operating Profit Margin (TTM) | -0.13% | 39.72% |
| Gross Profit Margin (TTM) | 35.04% | 90.20% |
Financial Strength
Current Ratio (MRQ)
BAX
1.84
Health Care Equipment & Supplies Industry
- Max
- 4.97
- Q3
- 2.92
- Median
- 2.12
- Q1
- 1.54
- Min
- 0.86
BAX’s Current Ratio of 1.84 aligns with the median group of the Health Care Equipment & Supplies industry, indicating that its short-term liquidity is in line with its sector peers.
DOCS
7.79
Health Care Technology Industry
- Max
- 7.79
- Q3
- 6.49
- Median
- 6.03
- Q1
- 3.62
- Min
- 2.96
DOCS’s Current Ratio of 7.79 is in the upper quartile for the Health Care Technology industry. This signifies a strong liquidity position, suggesting the company is well-equipped to cover its immediate liabilities compared to its peers.
Debt-to-Equity Ratio (MRQ)
BAX
1.31
Health Care Equipment & Supplies Industry
- Max
- 1.62
- Q3
- 0.74
- Median
- 0.47
- Q1
- 0.15
- Min
- 0.00
BAX’s leverage is in the upper quartile of the Health Care Equipment & Supplies industry, with a Debt-to-Equity Ratio of 1.31. While this approach can boost equity growth, it also exposes the company to greater financial vulnerability.
DOCS
0.00
Health Care Technology Industry
- Max
- 0.14
- Q3
- 0.10
- Median
- 0.01
- Q1
- 0.00
- Min
- 0.00
Falling into the lower quartile for the Health Care Technology industry, DOCS’s Debt-to-Equity Ratio of 0.00 points to a conservative financing strategy. This results in lower financial risk but potentially limits strategic investments compared to more leveraged competitors.
Interest Coverage Ratio (TTM)
BAX
0.20
Health Care Equipment & Supplies Industry
- Max
- 56.35
- Q3
- 24.86
- Median
- 9.84
- Q1
- 3.86
- Min
- -21.65
BAX’s Interest Coverage Ratio of 0.20 is a critical concern. A value below 1.0 means operating earnings are insufficient to cover interest expenses, indicating severe financial strain and high default risk.
DOCS
--
Health Care Technology Industry
- Max
- 224.12
- Q3
- 224.12
- Median
- 219.00
- Q1
- 219.00
- Min
- 219.00
Interest Coverage Ratio data for DOCS is currently unavailable.
Financial Strength at a Glance
| Symbol | BAX | DOCS |
|---|---|---|
| Current Ratio (MRQ) | 1.84 | 7.79 |
| Quick Ratio (MRQ) | 0.95 | 7.26 |
| Debt-to-Equity Ratio (MRQ) | 1.31 | 0.00 |
| Interest Coverage Ratio (TTM) | 0.20 | -- |
Growth
Revenue Growth
EPS Growth
Dividend
Dividend Yield (TTM)
BAX
4.36%
Health Care Equipment & Supplies Industry
- Max
- 4.36%
- Q3
- 1.87%
- Median
- 0.82%
- Q1
- 0.00%
- Min
- 0.00%
With a Dividend Yield of 4.36%, BAX offers a more attractive income stream than most of its peers in the Health Care Equipment & Supplies industry, signaling a strong commitment to shareholder returns.
DOCS
0.00%
Health Care Technology Industry
- Max
- 0.77%
- Q3
- 0.62%
- Median
- 0.19%
- Q1
- 0.05%
- Min
- 0.00%
DOCS currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.
Dividend Payout Ratio (TTM)
BAX
90.20%
Health Care Equipment & Supplies Industry
- Max
- 160.00%
- Q3
- 67.77%
- Median
- 28.21%
- Q1
- 0.00%
- Min
- 0.00%
BAX’s Dividend Payout Ratio of 90.20% is in the upper quartile for the Health Care Equipment & Supplies industry. This indicates a strong commitment to shareholder returns but also suggests that a smaller portion of earnings is retained for reinvestment compared to many peers.
DOCS
0.00%
Health Care Technology Industry
- Max
- 101.92%
- Q3
- 87.10%
- Median
- 42.63%
- Q1
- 10.66%
- Min
- 0.00%
DOCS has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.
Dividend at a Glance
| Symbol | BAX | DOCS |
|---|---|---|
| Dividend Yield (TTM) | 4.36% | 0.00% |
| Dividend Payout Ratio (TTM) | 90.20% | 0.00% |
Valuation
Price-to-Earnings Ratio (TTM)
BAX
--
Health Care Equipment & Supplies Industry
- Max
- 67.59
- Q3
- 41.41
- Median
- 33.11
- Q1
- 22.82
- Min
- 8.68
P/E Ratio data for BAX is currently unavailable.
DOCS
35.02
Health Care Technology Industry
- Max
- 225.71
- Q3
- 183.85
- Median
- 51.77
- Q1
- 45.26
- Min
- 35.02
In the lower quartile for the Health Care Technology industry, DOCS’s P/E Ratio of 35.02 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.
Price-to-Sales Ratio (TTM)
BAX
0.85
Health Care Equipment & Supplies Industry
- Max
- 9.49
- Q3
- 5.41
- Median
- 2.92
- Q1
- 1.97
- Min
- 0.61
In the lower quartile for the Health Care Equipment & Supplies industry, BAX’s P/S Ratio of 0.85 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.
DOCS
14.26
Health Care Technology Industry
- Max
- 117.92
- Q3
- 92.41
- Median
- 15.08
- Q1
- 8.11
- Min
- 6.06
DOCS’s P/S Ratio of 14.26 aligns with the market consensus for the Health Care Technology industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
Price-to-Book Ratio (MRQ)
BAX
1.62
Health Care Equipment & Supplies Industry
- Max
- 10.77
- Q3
- 6.04
- Median
- 3.32
- Q1
- 2.31
- Min
- 0.83
BAX’s P/B Ratio of 1.62 is in the lower quartile for the Health Care Equipment & Supplies industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.
DOCS
12.51
Health Care Technology Industry
- Max
- 115.01
- Q3
- 89.39
- Median
- 9.75
- Q1
- 4.04
- Min
- 3.06
DOCS’s P/B Ratio of 12.51 is within the conventional range for the Health Care Technology industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.
Valuation at a Glance
| Symbol | BAX | DOCS |
|---|---|---|
| Price-to-Earnings Ratio (TTM) | -- | 35.02 |
| Price-to-Sales Ratio (TTM) | 0.85 | 14.26 |
| Price-to-Book Ratio (MRQ) | 1.62 | 12.51 |
| Price-to-Free Cash Flow Ratio (TTM) | 16.75 | 28.39 |